EP3716979
Samsetning af 4-pýrimídínsúlfamíð-afleiðu með SGLT-2 hindra til meðhöndlunar á endóþelín-tengdum sjúkdómum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.11.2018EP published:
9.4.2025EP application number:
18814821.7
EP translation filed:
25.6.2025Grant published:
15.7.2025EPO information:
European Patent Register
Max expiry date:
28.11.2038Expiry date:
28.11.2026Next due date:
30.11.2026
Title in English:
COMBINATION OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH AN SGLT-2 INHIBITOR FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASESLanguage of the patent:
English
Timeline
Today
29.11.2018EP application
9.4.2025EP Publication
25.6.2025Translation submitted
15.7.2025Registration published
28.11.2026Expires
Owner
Name:
Idorsia Pharmaceuticals LtdAddress:
Hegenheimermattweg 91, 4123 Allschwil, CH
Inventor
Name:
BELLET, MarcAddress:
4123 Allschwil, CH
Name:
IGLARZ, MarcAddress:
4123 Allschwil, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2017/081050Date:
30.11.2017Country:
WO
Classification
Categories:
A61K 31/506, A61K 31/70, A61K 31/7042, A61K 31/7048, A61K 31/7056, A61P 9/10, A61P 17/02, A61P 13/12, A61P 9/12, A61P 3/10
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 11.11.2025
Expires: 28.11.2026
Payer: G.H. Sigurgeirsson ehf.